{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:29:15Z","timestamp":1792495755518,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.psychres.2016.12.010","type":"journal-article","created":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T13:18:43Z","timestamp":1481375923000},"page":"182-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Children with ADHD and symptoms of oppositional defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed \u2013 Results from a randomized, double-blind, placebo-controlled clinical trial"],"prefix":"10.1016","volume":"251","author":[{"given":"Leila","family":"Jahangard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh","family":"Akbarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Haghighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ahmadpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Keshavarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafez","family":"Bajoghli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena","family":"Sadeghi Bahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Holsboer-Trachsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2016.12.010_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/1044546041649020","article-title":"Risperidone effects in the presence\/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ","volume":"14","author":"Aman","year":"2004","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"47\u201360","key":"10.1016\/j.psychres.2016.12.010_bib2","first-page":"e1","article-title":"What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit\/hyperactivity disorder?","volume":"53","author":"Aman","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2016.12.010_bib3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ridd.2008.07.004","article-title":"Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children","volume":"30","author":"Aman","year":"2009","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.psychres.2016.12.010_bib4","unstructured":"American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., Washington, DC"},{"key":"10.1016\/j.psychres.2016.12.010_bib5","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.5812\/ijp.265","article-title":"Risperidone versus methylphenidate in treatment of preschool children with attention-deficit hyperactivity disorder","volume":"25","author":"Arabgol","year":"2015","journal-title":"Iran. J. Pediatr."},{"key":"10.1016\/j.psychres.2016.12.010_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00787-014-0563-6","article-title":"Trends in psychopharmacologic treatment of tic disorders in children and adolescents in Germany","volume":"24","author":"Bachmann","year":"2015","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2016.12.010_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/026988110201600113","article-title":"A systematic review of the use of atypical antipsychotics in autism","volume":"16","author":"Barnard","year":"2002","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2016.12.010_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0140-6736(05)66915-2","article-title":"Attention-deficit hyperactivity disorder","volume":"366","author":"Biederman","year":"2005","journal-title":"Lancet (Lond., Engl.)"},{"key":"10.1016\/j.psychres.2016.12.010_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1359104502007002009","article-title":"Parental assessments of the efficacy of risperidone in attention deficit hyperactivity disorder","volume":"7","author":"Bramble","year":"2002","journal-title":"Clin. Child Psychol. Psychiatry"},{"key":"10.1016\/j.psychres.2016.12.010_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1023\/A:1022602400621","article-title":"The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliabilty, and criterion validity","volume":"26","author":"Conners","year":"1998","journal-title":"J. Abnorm. Child Psychol."},{"key":"10.1016\/j.psychres.2016.12.010_bib11","article-title":"Evaluating an individualized lifestyle and life skills intervention to prevent antipsychotic-induced weight gain in first-episode psychosis","author":"Curtis","year":"2015","journal-title":"Early Inter. Psychiatry"},{"key":"10.1016\/j.psychres.2016.12.010_bib12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1517\/14740338.2014.906579","article-title":"Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature review","volume":"13","author":"De Hert","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.psychres.2016.12.010_bib13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/jcpp.12271","article-title":"Practitioner review: long-term pharmacological treatment of pediatric bipolar disorder","volume":"55","author":"Diaz-Caneja","year":"2014","journal-title":"J. Child Psychol. Psychiatry Allied Discip."},{"key":"10.1016\/j.psychres.2016.12.010_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/jc.2014-3421","article-title":"Clinical review: drugs commonly associated with weight change: a systematic review and meta-analysis","volume":"100","author":"Domecq","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psychres.2016.12.010_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000236081","article-title":"Prolactinoma in children and adolescents","volume":"72","author":"Fideleff","year":"2009","journal-title":"Horm. Res."},{"issue":"Suppl. 6","key":"10.1016\/j.psychres.2016.12.010_bib16","first-page":"S30","article-title":"Atypical antipsychotics in the treatment of children and adolescents: clinical applications","volume":"65","author":"Findling","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"948\u201359","key":"10.1016\/j.psychres.2016.12.010_bib17","first-page":"e1","article-title":"Risperidone added to parent training and stimulant medication: effects on attention-deficit\/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression","volume":"53","author":"Gadow","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2016.12.010_bib18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.283.5400.397","article-title":"Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity","volume":"283","author":"Gainetdinov","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.psychres.2016.12.010_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1517\/14740338.2015.979150","article-title":"Do antipsychotics increase diabetes risk in children and adolescents?","volume":"14","author":"Galling","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.psychres.2016.12.010_bib20","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00787-013-0498-3","article-title":"Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges","volume":"23","author":"Glennon","year":"2014","journal-title":"Eur. Child Adolesc. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.psychres.2016.12.010_bib21","article-title":"Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit\/Hyperactivity Disorder","volume":"6","author":"Greenhill","year":"2002","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.psychres.2016.12.010_bib22","doi-asserted-by":"crossref","unstructured":"Guy W., 1976. Clinical global impression scale. The ECDEU Assessment Manual for Psychopharmacology-Revised. Volume DHEW Publ No ADM 76;338:218-22.","DOI":"10.1037\/e591322011-001"},{"key":"10.1016\/j.psychres.2016.12.010_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0165025413515627","article-title":"Will they like me? Adolescents' emotional responses to peer evaluation","volume":"38","author":"Guyer","year":"2014","journal-title":"Int J. Behav. Dev."},{"key":"10.1016\/j.psychres.2016.12.010_bib24","first-page":"191","article-title":"Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone","volume":"11","author":"Hongkaew","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.psychres.2016.12.010_bib25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.pharma.2013.12.009","article-title":"Methylphenidate-risperidone combination in child psychiatry: a retrospective analysis of 44 cases","volume":"72","author":"Javelot","year":"2014","journal-title":"Ann. Pharm. Fr."},{"key":"10.1016\/j.psychres.2016.12.010_bib26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1017\/S0012162203001282","article-title":"Attention-deficit-hyperactivity disorder with and without oppositional defiant disorder in 3- to 7-year-old children","volume":"45","author":"Kadesjo","year":"2003","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.psychres.2016.12.010_bib27","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/15622975.2014.922698","article-title":"In a randomized case-control trial with 10-years olds suffering from attention deficit\/hyperactivity disorder (ADHD) sleep and psychological functioning improved during a 12-week sleep-training program","volume":"15","author":"Keshavarzi","year":"2014","journal-title":"World J. Biol. Psychiatry : Off. J. World Fed. Soc. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2016.12.010_bib28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.comppsych.2009.09.002","article-title":"Does oppositional defiant disorder have temperament and psychopathological profiles independent of attention deficit\/hyperactivity disorder?","volume":"51","author":"Kim","year":"2010","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.psychres.2016.12.010_bib29","first-page":"171","article-title":"Metabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management","volume":"5","author":"Krill","year":"2014","journal-title":"Adolesc. Health Med. Ther."},{"key":"10.1016\/j.psychres.2016.12.010_bib30","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/cap.2011.0015","article-title":"Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents","volume":"21","author":"Maayan","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2016.12.010_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/YIC.0000000000000063","article-title":"Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents","volume":"30","author":"Margari","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2016.12.010_bib32","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken","year":"2002","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.psychres.2016.12.010_bib33","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1176\/appi.ajp.162.9.1621","article-title":"Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families","volume":"162","author":"McGough","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2016.12.010_bib34","first-page":"212","article-title":"The therapeutic effectiveness of risperidone on negative symptoms of schizophrenia in comparison with haloperidol: a randomized clinical trial","volume":"5","author":"Mirabzadeh","year":"2014","journal-title":"Basic Clin. Neurosci."},{"key":"10.1016\/j.psychres.2016.12.010_bib35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00787-015-0738-9","article-title":"Comorbidity and correlates of disruptive mood dysregulation disorder in 6-8-year-old children with ADHD","volume":"25","author":"Mulraney","year":"2016","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2016.12.010_bib36","first-page":"390130","article-title":"Youth, caregiver, and prescriber experiences of antipsychotic-related weight gain","volume":"2013","author":"Murphy","year":"2013","journal-title":"ISRN Obes."},{"key":"10.1016\/j.psychres.2016.12.010_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1517\/14740338.2015.974549","article-title":"Weight gain and antipsychotics: a drug safety review","volume":"14","author":"Musil","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.psychres.2016.12.010_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4306\/pi.2015.12.1.55","article-title":"The short-term effects of risperidone-induced hyperprolactinemia on lipid metabolism in drug-naive children and adolescents","volume":"12","author":"Park","year":"2015","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.psychres.2016.12.010_bib39","first-page":"421","article-title":"The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review","volume":"28","author":"Peuskens","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2016.12.010_bib40","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/ajp.2007.164.6.942","article-title":"The worldwide prevalence of ADHD: a systematic review and metaregression analysis","volume":"164","author":"Polanczyk","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2016.12.010_bib41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ije\/dyt261","article-title":"ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis","volume":"43","author":"Polanczyk","year":"2014","journal-title":"Int J. Epidemiol."},{"key":"10.1016\/j.psychres.2016.12.010_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/1687-9856-2010-159402","article-title":"Hyperprolactinemia with antipsychotic drugs in children and adolescents","volume":"2010","author":"Rosenbloom","year":"2010","journal-title":"Int J. Pediatr. Endocrinol."},{"key":"10.1016\/j.psychres.2016.12.010_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0278-5846(01)00264-0","article-title":"A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders","volume":"26","author":"Simeon","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"Suppl. 4","key":"10.1016\/j.psychres.2016.12.010_bib44","first-page":"S81","article-title":"Female mate value at a glance: relationship of waist-to-hip ratio to health, fecundity and attractiveness","volume":"23","author":"Singh","year":"2002","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.psychres.2016.12.010_bib45","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eurpsy.2007.09.007","article-title":"Subtype differences in adults with attention-deficit\/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment","volume":"23","author":"Sobanski","year":"2008","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2016.12.010_bib46","first-page":"CD007011","article-title":"Risperidone for attention-deficit hyperactivity disorder in people with intellectual disabilities","author":"Thomson","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.psychres.2016.12.010_bib47","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s13311-012-0135-8","article-title":"The prevalence of DSM-IV attention-deficit\/hyperactivity disorder: a meta-analytic review","volume":"9","author":"Willcutt","year":"2012","journal-title":"Neurother.: J. Am. Soc. Exp. NeuroTher."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116316298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116316298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T07:53:11Z","timestamp":1568620391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178116316298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":47,"alternative-id":["S0165178116316298"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2016.12.010","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Children with ADHD and symptoms of oppositional defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed \u2013 Results from a randomized, double-blind, placebo-controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2016.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}